Quach, H., Pour, L., Grosicki, S., Sia, H., Minarik, J., Byun, J. M., Touzeau, C., Liberatore, C., Sullivan, S. T., Leip, E., Shaikh, E., Viqueira, A., Dimopoulos, M. A. (2025). Elranatamab in combination with daratumumab and lenalidomide (EDR) in patients with newly diagnosed multiple myeloma (NDMM) not eligible for transplant: Initial results from MagnetisMM-6 part 1.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7504